Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
investing
3
×
life sciences
national blog main
new york blog main
3
×
boston blog main
boston top stories
fda
new york top stories
startups
achaogen
adams street partners
agios pharmaceuticals
antibiotics
antisense oligonucleotide
benzodiazepines
beta lactamase inhibitor
biogen
biomedical advanced research and development authority (barda)
blackstone group
blackstone life sciences
boston
cancer
cancer drugs
columbia university
david e. shaw
david goldstein
deals
depression
drug discovery
drug resistance
drugs
enasidenib
epi4k
epilepsy
essential tremor
hatteras venture partners
ipo
ivosidenib
What
medicines
3
×
aims
backed
bacteria
biopharma
business
cause
ceo
company
company’s
course
development
discover
disease
drug
drugs
epilepsy
exited
experimental
fighting
genes
genetic
growing
handiwork
helped
infections
infectious
internal
ipo
landscape
launches
links
marcio
melinta
mutations
neuro
new
pipeline
praxis
precision
Language
unset
Current search:
medicines
×
investing
×
" new york blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
